IP Library Granted Patent US 7,790,391
Granted Patent B2
US 7,790,391 · App. 12/058,032 · Granted Sep 7, 2010

Methods of equalizing representation levels of nucleic acid targets

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,790,391
App. No.
12/058,032
Granted
Sep 7, 2010
Kind
B2
Abstract

The disclosure provides methods of reducing the range of representation levels of nucleic acid targets. The methods are particularly useful for multi-target analyses benefiting from a low variance of target representations, such as, e.g., single molecule sequencing and/or heterozygous genotyping, and pathogen diagnosis. Two general methods are provided. In Method 1, starting concentrations of probes are adjusted. In Method 2, target-specific probes are “binned,” i.e., several subsets of probes are selected based on similar representation levels. Thereafter, each subset of corresponding targets is extracted, with or without amplification, using a separate portion of the sample (i.e., separate vessels).

Claims (36)

1. A method of equalizing amounts of nucleic acid targets in a sample, the method comprising:

a) contacting a plurality of probes with a sample comprising a plurality of targets;

b) capturing the plurality of nucleic acid targets with the plurality of probes;

c) optionally, amplifying the captured targets using the plurality of probes;

d) determining an initial range of amounts of different captured nucleic acid targets; and

e) repeating steps a), b), and c) if performed, at starting concentrations of the probes adjusted to reduce said initial range, thereby producing a final sample.

2. The method of claim 1 , wherein the step of amplifying the captured targets is required.

3. The method of claim 1 , wherein the targets are amplified by multiplex PCR.

4. The method of claim 1 , further comprising f) analyzing the targets obtained in the final sample.

5. The method of claim 4 , wherein the targets are analyzed by sequencing.

6. The method of claim 5 , wherein the sequencing is sequencing by synthesis or ligation.

7. The method of claim 6 , wherein the sequencing by synthesis is performed at a single molecule resolution.

8. The method of claim 1 , wherein the capturing step comprises circularizing probes annealed to targets and removing non-circularized nucleic acids.

9. The method of claim 1 , wherein the range of representation levels is reduced by at least two-fold.

10. The method of claim 1 , wherein the initial range of representation levels is greater than 100× and/or the reduced range of representation levels is less than 50×.

11. The method of claim 1 , wherein the starting concentrations of at least five probes are adjusted at least two-fold up or down.

12. A method equalizing amounts of nucleic acid targets, the method comprising:

a) introducing a plurality of probes to a sample comprising a plurality of targets;

b) capturing the plurality of nucleic acid targets with the plurality of probes;

c) optionally, amplifying the captured targets using the plurality of probes;

d) determining an initial range of amounts of the captured nucleic acid targets;

e) selecting two or more subsets of targets/probes so that each of the subsets contains targets of a range of amounts that is reduced relative to the initial range; and

f) repeating steps a), b), and c) if performed, using separate samples so that each sample contains only targets/probes of different selected subsets.

13. The method of claim 12 , wherein the method further comprises g) combining the samples produced in step f) or portions thereof to produce a final sample.

14. The method of claim 12 , wherein the step of amplifying the captured targets is required.

15. The method of claim 12 , wherein the targets are amplified by multiplex PCR.

16. The method of claim 15 , wherein in two or more multiplex amplification reactions at least five targets are amplified in each.

17. The method of claim 12 , further comprising h) analyzing targets in the combined sample.

18. The method of claim 17 , wherein the targets are analyzed by sequencing.

19. The method of claim 18 , wherein the sequencing is sequencing by synthesis or ligation.

20. The method of claim 19 , wherein the sequencing by synthesis is performed at a single molecule resolution.

21. The method of claim 12 , wherein the capturing step comprises circularizing probes annealed to respective targets and removing non-circularized nucleic acids.

22. The method of claim 12 , wherein the range of representation levels is reduced by at least two-fold.

23. The method of claim 12 , wherein the initial range of representation levels is greater than 100× and/or the reduced range of representation levels is less than 50×.

24. The method of claim 12 , wherein five or more subsets of probes are selected.

25. The method of claim 1 , wherein two or more subsets of probes comprise at least five probes each.

Assignments (8)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2013
From: HELICOS BIOSCIENCES CORPORATION
To: FLUIDIGM CORPORATION
Reel/Frame 030714/0546 →
LICENSE Recorded Jun 28, 2013
From: FLUIDIGM CORPORATION
To: PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Reel/Frame 030714/0598 →
LICENSE Recorded Jun 28, 2013
From: FLUIDIGM CORPORATION
To: SEQLL, LLC
Reel/Frame 030714/0633 →
LICENSE Recorded Jun 28, 2013
From: FLUIDIGM CORPORATION
To: COMPLETE GENOMICS, INC.
Reel/Frame 030714/0686 →
LICENSE Recorded Jun 28, 2013
From: FLUIDIGM CORPORATION
To: ILLUMINA, INC.
Reel/Frame 030714/0783 →
RELEASE OF SECURITY INTEREST Recorded Jan 18, 2012
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: HELICOS BIOSCIENCES CORPORATION
Reel/Frame 027549/0565 →
SECURITY AGREEMENT Recorded Nov 22, 2010
From: HELICOS BIOSCIENCES CORPORATION
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 025388/0347 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 29, 2008
From: HARRIS, TIMOTHY; BOYCE, IV, JOHN J.
To: HELICOS BIOSCIENCES CORPORATION
Reel/Frame 021015/0260 →